Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

OMNICELL, INC. Director's Dealing 2020

Feb 11, 2020

31980_dirs_2020-02-11_1a79e418-13f3-411c-a8f8-38d5c78e1757.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OMNICELL, Inc (OMCL)
CIK: 0000926326
Period of Report: 2020-02-10

Reporting Person: Seidelmann Scott Peter (EVP, Chief Commercial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-02-10 Common Stock M 2833 Acquired 26474 Direct
2020-02-10 Common Stock S 600 $84.9066 Disposed 25874 Direct
2020-02-10 Common Stock S 1649 $86.5782 Disposed 24225 Direct
2020-02-10 Common Stock S 584 $87.3062 Disposed 23641 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-02-10 Stock Options NQ (Right to Buy) $43.30 M 2833 Disposed 2028-04-19 Common Stock (2833) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 23641 Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan.

F2: The price reported in Column 4 is the average price of $84.9066. The sold price range between $84.58 to $85.42. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: The price reported in Column 4 is the average price of $86.5782. The sold price range between $86.07 to $87.04. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: The price reported in Column 4 is the average price of $87.3062. The sold price range between $87.16 to $87.45. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.